Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 82 articles:
HTML format
Text format



Single Articles


    September 2017
  1. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
    A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
    PubMed     Text format     Abstract available


  2. LIU J, Lv L, Gong J, Tan Y, et al
    Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
    PubMed     Text format     Abstract available


    August 2017
  3. FOUNTZILAS G, Psyrri A, Giannoulatou E, Tikas I, et al
    Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
    Int J Cancer. 2017 Aug 31. doi: 10.1002/ijc.31023.
    PubMed     Text format     Abstract available


  4. TWAROCK S, Reichert C, Peters U, Gorski DJ, et al
    Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
    Int J Cancer. 2017;141:791-804.
    PubMed     Text format     Abstract available


    July 2017
  5. WANG YK, Chuang YS, Wu TS, Lee KW, et al
    Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors and outcomes.
    Int J Cancer. 2017 Jul 30. doi: 10.1002/ijc.30911.
    PubMed     Text format     Abstract available


  6. KAWAKITA D, Amy Lee YC, Turati F, Parpinel M, et al
    Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30886.
    PubMed     Text format     Abstract available


  7. ZAMORA-ROS R, Beraud V, Franceschi S, Cayssials V, et al
    Consumption of fruits, vegetables, and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2017 Jul 8. doi: 10.1002/ijc.30880.
    PubMed     Text format     Abstract available


    June 2017
  8. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Text format     Abstract available


  9. BOSCOLO-RIZZO P, Dietz A
    The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30837.
    PubMed     Text format    


  10. YOU R, Sun R, Hua YJ, Li CF, et al
    Cetuximab or Nimotuzumab plus Intensity-modulated Radiotherapy Versus Cisplatin plus Intensity-modulated Radiotherapy for Stage II-IVb Nasopharyngeal Carcinoma.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30819.
    PubMed     Text format     Abstract available


  11. MILLRUD CR, Kagedal A, Kumlien Georen S, Winqvist O, et al
    NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC.
    Int J Cancer. 2017;140:2557-2567.
    PubMed     Text format     Abstract available


    May 2017
  12. KLINGHAMMER K, Otto R, Raguse JD, Albers AE, et al
    Basal subtype is predictive for response to cetuximab treatment in patient derived xenografts of squamous cell head and neck cancer.
    Int J Cancer. 2017 May 30. doi: 10.1002/ijc.30808.
    PubMed     Text format     Abstract available


  13. CARIOLI G, Negri E, Kawakita D, Garavello W, et al
    Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.
    Int J Cancer. 2017;140:2256-2264.
    PubMed     Text format     Abstract available


  14. BALERMPAS P, Rodel F, Krause M, Linge A, et al
    The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2017 May 8. doi: 10.1002/ijc.30770.
    PubMed     Text format     Abstract available


  15. MEYERS TJ, Chang SC, Chang PY, Morgenstern H, et al
    Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
    Int J Cancer. 2017;140:2040-2050.
    PubMed     Text format     Abstract available


  16. SPROLL C, Freund AK, Hassel A, Holbling M, et al
    Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
    Int J Cancer. 2017;140:2112-2124.
    PubMed     Text format     Abstract available


    April 2017
  17. RENKONEN S, Lee M, Makitie A, Lindstrom LS, et al
    Site-specific familial risk and survival of familial and sporadic head and neck cancer.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30751.
    PubMed     Text format     Abstract available


  18. LU Z, Zhang C, Sheng J, Shen J, et al
    T cell receptor beta-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.
    Int J Cancer. 2017 Apr 21. doi: 10.1002/ijc.30743.
    PubMed     Text format     Abstract available


  19. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Text format     Abstract available


  20. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Text format     Abstract available


  21. LEVINGSTON CA, Young MR
    Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Int J Cancer. 2017;140:1609-1619.
    PubMed     Text format     Abstract available


  22. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


    March 2017
  23. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Text format     Abstract available


  24. CHEOL PARK G, Roh JL, Cho KJ, Seung Kim J, et al
    18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.
    Int J Cancer. 2017;140:1405-1412.
    PubMed     Text format     Abstract available


  25. PRIGGE ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M, et al
    Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2017;140:1186-1198.
    PubMed     Text format     Abstract available


  26. SCHNELLE C, Whiteman DC, Porceddu SV, Panizza BJ, et al
    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
    Int J Cancer. 2017;140:1027-1034.
    PubMed     Text format     Abstract available


    February 2017
  27. SUGASE T, Takahashi T, Serada S, Nakatsuka R, et al
    Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30666.
    PubMed     Text format     Abstract available


  28. JEHANNIN-LIGIER K, Belot A, Guizard AV, Bossard N, et al
    Incidence Trends for Potentially Human Papilloma Virus-Related and -Unrelated Head and Neck Cancers in France using Population-based Cancer Registries Data: 1980-2012.
    Int J Cancer. 2017 Feb 6. doi: 10.1002/ijc.30631.
    PubMed     Text format     Abstract available


  29. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Text format     Abstract available


    January 2017
  30. ANANTHARAMAN D, Abedi-Ardekani B, Beachler DC, Gheit T, et al
    Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30608.
    PubMed     Text format     Abstract available


  31. FALCONER H, Yin L, Bellocco R, Altman D, et al
    Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30606.
    PubMed     Text format     Abstract available


  32. MCCORMACK VA, Menya D, Munishi MO, Dzamalala C, et al
    Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.
    Int J Cancer. 2017;140:259-271.
    PubMed     Text format     Abstract available


  33. KANEMARU A, Yamamoto K, Kawaguchi M, Fukushima T, et al
    Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
    Int J Cancer. 2017;140:130-141.
    PubMed     Text format     Abstract available


    December 2016
  34. HATANO T, Sano D, Takahashi H, Hyakusoku H, et al
    Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30589.
    PubMed     Text format     Abstract available


  35. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


  36. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available


    November 2016
  37. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Text format     Abstract available


    October 2016
  38. MAO L, Deng WW, Yu GT, Bu LL, et al
    Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Int J Cancer. 2016 Oct 31. doi: 10.1002/ijc.30493.
    PubMed     Text format     Abstract available


  39. CHEN X, Yuan Z, Lu M, Zhang Y, et al
    Poor oral health is associated with an increased risk of esophageal squamous cell carcinoma - a population-based case-control study in China.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30484.
    PubMed     Text format     Abstract available


    September 2016
  40. OGHUMU S, Knobloch TJ, Terrazas C, Varikuti S, et al
    Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
    Int J Cancer. 2016;139:1379-90.
    PubMed     Text format     Abstract available


  41. RAMAYANTI O, Juwana H, Verkuijlen SA, Adham M, et al
    Epstein-Barr Virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30418.
    PubMed     Text format     Abstract available


    August 2016
  42. LIU Z, Coghill AE, Pfeiffer RM, Hsu WL, et al
    Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30390.
    PubMed     Text format     Abstract available


  43. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Text format     Abstract available


  44. VAN DIJK BA, Brands MT, Geurts SM, Merkx MA, et al
    Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
    Int J Cancer. 2016;139:574-83.
    PubMed     Text format     Abstract available


    July 2016
  45. VON MASSENHAUSEN A, Sanders C, Bragelmann J, Konantz M, et al
    Targeting DDR2 in Head and Neck Squamous Cell Carcinoma with Dasatinib.
    Int J Cancer. 2016 Jul 19. doi: 10.1002/ijc.30279.
    PubMed     Text format     Abstract available


  46. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Text format     Abstract available


  47. AL-HEBSHI NN, Li S, Nasher AT, El-Setouhy M, et al
    Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Int J Cancer. 2016;139:363-72.
    PubMed     Text format     Abstract available


    June 2016
  48. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Text format     Abstract available


  49. QUAN H, Fang L, Pan H, Deng Z, et al
    An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
    Int J Cancer. 2016;138:2952-62.
    PubMed     Text format     Abstract available


  50. XIE SH, Lagergren J
    A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.
    Int J Cancer. 2016;138:2813-9.
    PubMed     Text format     Abstract available


    May 2016
  51. CHIN YM, Ping Tan L, Abdul Aziz N, Mushiroda T, et al
    Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort.
    Int J Cancer. 2016 May 28. doi: 10.1002/ijc.30207.
    PubMed     Text format     Abstract available


  52. LAPRISE C, Puthiyannal Shahul H, Arekunnath Madathil S, Soman Thekkepurakkal A, et al
    Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30201.
    PubMed     Text format     Abstract available


  53. YOUNG MR, Levingston CA, Johnson SD
    Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
    Int J Cancer. 2016;138:2487-98.
    PubMed     Text format     Abstract available


  54. WAGNER S, Wittekindt C, Reuschenbach M, Hennig B, et al
    CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;138:2263-73.
    PubMed     Text format     Abstract available


    March 2016
  55. TCHEANDJIEU C, Lesueur F, Sanchez M, Baron-Dubourdieu D, et al
    Fine-Mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30088.
    PubMed     Text format     Abstract available


  56. LIERSCH-LOHN B, Slavova N, Buhr HJ, Bennani-Baiti IM, et al
    Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Int J Cancer. 2016;138:1220-31.
    PubMed     Text format     Abstract available


  57. EK WE, Lagergren K, Cook M, Wu AH, et al
    Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Int J Cancer. 2016;138:1146-52.
    PubMed     Text format     Abstract available


  58. SHOULTZ-HENLEY S, Garden AS, Mohamed AS, Sheu T, et al
    Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation.
    Int J Cancer. 2016;138:1290-7.
    PubMed     Text format     Abstract available


  59. CRUMP C, Sundquist J, Sieh W, Winkleby MA, et al
    Fetal growth and subsequent maternal risk of thyroid cancer.
    Int J Cancer. 2016;138:1085-93.
    PubMed     Text format     Abstract available


  60. ZHU DD, Zhang J, Deng W, Yip YL, et al
    Significance of NF-kappaB activation in immortalization of nasopharyngeal epithelial cells.
    Int J Cancer. 2016;138:1175-85.
    PubMed     Text format     Abstract available


    February 2016
  61. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Text format     Abstract available


  62. UPRETI D, Zhang ML, Bykova E, Kung SK, et al
    Change in CD3zeta-chain expression is an independent predictor of disease status in Head and Neck Cancer Patients.
    Int J Cancer. 2016 Feb 16. doi: 10.1002/ijc.30046.
    PubMed     Text format     Abstract available


  63. NG HY, Ko JM, Yu VZ, Ip JC, et al
    DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
    Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30034.
    PubMed     Text format     Abstract available


  64. WANG HM, Cheng NM, Lee LY, Fang YH, et al
    Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Int J Cancer. 2016;138:731-8.
    PubMed     Text format     Abstract available


    January 2016
  65. VOJTECHOVA Z, Sabol I, Salakova M, Turek L, et al
    Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.
    Int J Cancer. 2016;138:386-95.
    PubMed     Text format     Abstract available


  66. GOROGH T, Quabius ES, Heidebrecht H, Nagy A, et al
    Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29986.
    PubMed     Text format     Abstract available


  67. HUI KF, Cheung AK, Choi CK, Yeung PL, et al
    Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Int J Cancer. 2016;138:125-36.
    PubMed     Text format     Abstract available


  68. WANGSA D, Chowdhury SA, Ryott M, Gertz EM, et al
    Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
    Int J Cancer. 2016;138:98-109.
    PubMed     Text format     Abstract available


  69. DRAHOS J, Xiao Q, Risch HA, Freedman ND, et al
    Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
    Int J Cancer. 2016;138:55-64.
    PubMed     Text format     Abstract available


    December 2015
  70. FRANCESCHI S, Combes JD, Dalstein V, Caudroy S, et al
    Deep brush-based cytology in tonsils resected for benign diseases.
    Int J Cancer. 2015;137:2994-9.
    PubMed     Text format     Abstract available


  71. CIRELLO V, Colombo C, Perrino M, De Leo S, et al
    Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the disease.
    Int J Cancer. 2015;137:2989-93.
    PubMed     Text format     Abstract available


  72. O'GRADY TJ, Gates MA, Boscoe FP
    Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
    Int J Cancer. 2015;137:2664-73.
    PubMed     Text format     Abstract available


    November 2015
  73. ZHANG F, Sturgis EM, Sun Y, Zhang Y, et al
    Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Int J Cancer. 2015;137:2454-61.
    PubMed     Text format     Abstract available


  74. BRAGANZA MZ, Potischman N, Park Y, Thompson FE, et al
    Adolescent and mid-life diet and subsequent risk of thyroid cancer in the NIH-AARP diet and health study.
    Int J Cancer. 2015;137:2413-23.
    PubMed     Text format     Abstract available


    October 2015
  75. LIN W, Ren FM, Ren ZF
    The contribution of radiotherapy to subsequent thyroid cancer risk may be confined to a subgroup of breast cancer patients.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29907.
    PubMed     Text format    


  76. SUN LM, Lin CL, Liang JA, Kao CH, et al
    Authors' reply to Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29906.
    PubMed     Text format    


  77. MANCIKOVA V, Cruz R, Inglada-Perez L, Fernandez-Rozadilla C, et al
    Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.
    Int J Cancer. 2015;137:1870-8.
    PubMed     Text format     Abstract available


  78. ZHANG L, Huang X, Zhu X, Ge S, et al
    Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma.
    Int J Cancer. 2015 Oct 5. doi: 10.1002/ijc.29882.
    PubMed     Text format     Abstract available


    September 2015
  79. JIA Y, Wang H, Wang Y, Wang T, et al
    Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
    Int J Cancer. 2015;137:1095-106.
    PubMed     Text format     Abstract available


  80. GANDOLFI G, Sancisi V, Piana S, Ciarrocchi A, et al
    Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma.
    Int J Cancer. 2015;137:1001-11.
    PubMed     Text format     Abstract available


    July 2015
  81. DENT BM, Ogle LF, O'Donnell RL, Hayes N, et al
    High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29680.
    PubMed     Text format     Abstract available


  82. SUN LM, Lin CL, Liang JA, Huang WS, et al
    Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29667.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: